Events & Presentations

Arbutus Biopharma Corporation 2018 First Quarter Financial Results and Corporate Update

May 03,2018 1:30 PM PDT

Arbutus would like to correct a misspeak by Koert VandenEnden in this archived webcast. At 14:50, when Mr. VandenEnden said “Arbutus’ net loss for Q1 2018 was $15.7 million ($0.33 per common share),” he meant to say, “Arbutus’ net loss for Q1 2018 was $17.9 million ($0.36 per common share).

Back to previous page